Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma | MicrobiomeTrials← Back to trialsNCT07637526
Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2027-12-31
Enrollment target: 100 participants Other microbiome trials you might be interested in
Multiple Myeloma
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab…
Mobile, United StatesEst. completion Aug 30, 2026
Multiple Myeloma
The primary purpose is to determine the safety and tolerability of belantamab mafodotin in combination with nirogacestat…
Boston, United StatesEst. completion Apr 17, 2025
Phase 1
SUSPENDED
Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM)
Background:
Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatmen…
Bethesda, United StatesCompleted Jan 1, 2033